{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:04:17Z","timestamp":1793714657226,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004789","name":"Oxford University | John Fell Fund, University of Oxford","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004789","name":"Oxford University | John Fell Fund, University of Oxford","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cancer prediction algorithms are used in the UK to identify individuals at high probability of having a current, as yet undiagnosed cancer with the intention of improving early diagnosis and treatment. Here we develop and externally validate two diagnostic prediction algorithms to estimate the probability of having cancer for 15 cancer types. The first incorporates multiple predictors including age, sex, deprivation, smoking, alcohol, family history, medical diagnoses and symptoms (both general and cancer-specific symptoms). The second additionally includes commonly used blood tests (full blood count and liver function tests). We use multinomial logistic regression to develop separate equations in men and women to predict the absolute probability of 15 cancer types using a population of 7.46 million adults aged 18 to 84 years in England. We evaluate performance in two separate validation cohorts (total 2.64 million patients in England and 2.74 million from Scotland, Wales and Northern Ireland). The models have improved performance compared with existing models with improved discrimination, calibration, sensitivity and net benefit. These algorithms provide superior prediction estimates in the UK compared with existing scores and could lead to better clinical decision-making and potentially earlier diagnosis of cancer.<\/jats:p>","DOI":"10.1038\/s41467-025-57990-5","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:01:49Z","timestamp":1746608509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and external validation of prediction algorithms to improve early diagnosis of cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-7283","authenticated-orcid":false,"given":"J.","family":"Hippisley-Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"57990_CR1","unstructured":"Cancer Research UK. Cancer in the UK (Cancer Research UK, 2024)."},{"key":"57990_CR2","unstructured":"Department of Health. Improving Outcomes: A Strategy for Cancer (Department of Health, 2011)."},{"key":"57990_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","volume":"16","author":"G Rubin","year":"2015","unstructured":"Rubin, G. et al. The expanding role of primary care in cancer control. Lancet Oncol. 16, 1231\u20131272 (2015).","journal-title":"Lancet Oncol."},{"key":"57990_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3399\/bjgp13X660733","volume":"63","author":"J Hippisley-Cox","year":"2013","unstructured":"Hippisley-Cox, J. & Coupland, C. Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm. Br. J. Gen. Pract. 63, 11\u201321 (2013).","journal-title":"Br. J. Gen. Pract."},{"key":"57990_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/bjgp13X660724","volume":"63","author":"J Hippisley-Cox","year":"2013","unstructured":"Hippisley-Cox, J. & Coupland, C. Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm. Br. J. Gen. Pract. 63, 1\u201310 (2013).","journal-title":"Br. J. Gen. Pract."},{"key":"57990_CR6","first-page":"508","volume":"43","author":"J Emery","year":"2014","unstructured":"Emery, J. & Chiang, P. The role of risk tools in diagnosing cancer in primary care. Aust. Fam. Physician 43, 508\u2013512 (2014).","journal-title":"Aust. Fam. Physician"},{"key":"57990_CR7","unstructured":"National Institute for Clinical Excellence. Suspected Cancer: Recognition and Referral. NICE guideline [NG12], 378 (NICE, 2015)."},{"key":"57990_CR8","unstructured":"NHS England. Case-mix Adjusted Percentage of Cancers Diagnosed at Stages 1 and 2 in England, 2020 (NHS England, 2022)."},{"key":"57990_CR9","unstructured":"NHS England. The NHS Long Term Plan (NHS England, 2019)."},{"key":"57990_CR10","doi-asserted-by":"crossref","unstructured":"Tan, P. S. et al. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study. Gut 72, 512\u2013521 (2023).","DOI":"10.1136\/gutjnl-2021-326522"},{"key":"57990_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","volume":"36","author":"TH Nost","year":"2021","unstructured":"Nost, T. H. et al. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur. J. Epidemiol. 36, 841\u2013848 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"57990_CR12","doi-asserted-by":"publisher","first-page":"e556","DOI":"10.3399\/BJGP.2021.0563","volume":"72","author":"M Moullet","year":"2022","unstructured":"Moullet, M. et al. Pre-diagnostic clinical features and blood tests in patients with colorectal cancer: a retrospective linked-data study. Br. J. Gen. Pract. 72, e556\u2013e563 (2022).","journal-title":"Br. J. Gen. Pract."},{"key":"57990_CR13","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.3399\/bjgp20X710957","volume":"70","author":"LT Mounce","year":"2020","unstructured":"Mounce, L. T., Hamilton, W. & Bailey, S. E. Cancer incidence following a high-normal platelet count: cohort study using electronic healthcare records from English primary care. Br. J. Gen. Pract. 70, e622\u2013e628 (2020).","journal-title":"Br. J. Gen. Pract."},{"key":"57990_CR14","doi-asserted-by":"publisher","first-page":"l5774","DOI":"10.1136\/bmj.l5774","volume":"367","author":"J Watson","year":"2019","unstructured":"Watson, J., Mounce, L., Bailey, S. E., Cooper, S. L. & Hamilton, W. Blood markers for cancer. BMJ 367, l5774 (2019).","journal-title":"BMJ"},{"key":"57990_CR15","unstructured":"Cancer Research UK. Liver Cancer Statistics and Symptoms (Cancer Research UK, 2024)."},{"key":"57990_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/sim.4780091109","volume":"9","author":"JC Van Houwelingen","year":"1990","unstructured":"Van Houwelingen, J. C. & Le Cessie, S. Predictive value of statistical models. Stat. Med. 9, 1303\u20131325 (1990).","journal-title":"Stat. Med."},{"key":"57990_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-019-0064-7","volume":"3","author":"AJ Vickers","year":"2019","unstructured":"Vickers, A. J., van Calster, B. & Steyerberg, E. W. A simple, step-by-step guide to interpreting decision curve analysis. Diagn. Progn. Res. 3, 18 (2019).","journal-title":"Diagn. Progn. Res."},{"key":"57990_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/fampra\/cmw051","volume":"33","author":"SW Merriel","year":"2016","unstructured":"Merriel, S. W., Carroll, R., Hamilton, F. & Hamilton, W. Association between unexplained hypoalbuminaemia and new cancer diagnoses in UK primary care patients. Fam. Pract. 33, 449\u2013452 (2016).","journal-title":"Fam. Pract."},{"key":"57990_CR19","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3390\/cancers12092348","volume":"12","author":"PS Virdee","year":"2020","unstructured":"Virdee, P. S. et al. The full blood count blood test for colorectal cancer detection: a systematic review, meta-analysis, and critical appraisal. Cancers 12, 2348 (2020).","journal-title":"Cancers"},{"key":"57990_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/fampra\/cmy018","volume":"35","author":"E Ankus","year":"2018","unstructured":"Ankus, E., Price, S. J., Ukoumunne, O. C., Hamilton, W. & Bailey, S. E. R. Cancer incidence in patients with a high normal platelet count: a cohort study using primary care data. Fam. Pract. 35, 671\u2013675 (2018).","journal-title":"Fam. Pract."},{"key":"57990_CR21","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.21037\/tcr-23-1190","volume":"2","author":"T,Zeng,Q,He,J Jiang","year":"2023","unstructured":"Jiang, T., Zeng, Q. & He, J. Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors? Transl. Cancer Res. 2, 2932\u20132945 (2023).","journal-title":"Transl. Cancer Res."},{"key":"57990_CR22","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/cancers13112749","volume":"13","author":"N Seyed Khoei","year":"2021","unstructured":"Seyed Khoei, N. et al. Associations between prediagnostic circulating bilirubin levels and risk of gastrointestinal cancers in the UK Biobank. Cancers 13, 2749 (2021).","journal-title":"Cancers"},{"key":"57990_CR23","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41416-024-02693-9","volume":"130","author":"AK Clift","year":"2024","unstructured":"Clift, A. K. et al. Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal\u2013external validation of a clinical risk prediction model. Br. J. Cancer 130, 1969\u20131978 (2024).","journal-title":"Br. J. Cancer"},{"key":"57990_CR24","unstructured":"NHS England. Faster Diagnosis Framework (NHS England, 2024)."},{"key":"57990_CR25","doi-asserted-by":"publisher","first-page":"j2099","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox, J., Coupland, C. & Brindle, P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357, j2099 (2017).","journal-title":"BMJ"},{"key":"57990_CR26","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41591-024-02905-y","volume":"30","author":"J Hippisley-Cox","year":"2024","unstructured":"Hippisley-Cox, J. et al. Development and validation of a new algorithm for improved cardiovascular risk prediction. Nat. Med. 30, 1440\u20131447 (2024).","journal-title":"Nat. Med."},{"key":"57990_CR27","doi-asserted-by":"crossref","unstructured":"Majeed, A. Sources, uses, strengths and limitations of data collected in primary care in England. Health Stat. Q. 21, 5\u201314 (2004).","DOI":"10.7748\/phc.14.3.5.s1"},{"key":"57990_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2015.11082","volume":"314","author":"MJ Pencina","year":"2015","unstructured":"Pencina, M. J. & D\u2019Agostino, R. B. Sr. Evaluating discrimination of risk prediction models: the C statistic. JAMA 314, 1063\u20131064 (2015).","journal-title":"JAMA"},{"key":"57990_CR29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/bmj.39171.637106.AE","volume":"334","author":"R Jones","year":"2007","unstructured":"Jones, R., Latinovic, R., Charlton, J. & Gulliford, M. C. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 334, 1040 (2007).","journal-title":"BMJ"},{"key":"57990_CR30","doi-asserted-by":"publisher","first-page":"b3094","DOI":"10.1136\/bmj.b3094","volume":"339","author":"R Jones","year":"2009","unstructured":"Jones, R., Charlton, J., Latinovic, R. & Gulliford, M. C. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ 339, b3094 (2009).","journal-title":"BMJ"},{"key":"57990_CR31","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1177\/09622802221102623","volume":"31","author":"EF Bonneville","year":"2022","unstructured":"Bonneville, E. F., Resche-Rigon, M., Schetelig, J., Putter, H. & de Wreede, L. C. Multiple imputation for cause-specific Cox models: assessing methods for estimation and prediction. Stat. Methods Med. Res. 31, 1860\u20131880 (2022).","journal-title":"Stat. Methods Med. Res."},{"key":"57990_CR32","doi-asserted-by":"crossref","unstructured":"Rubin, D. B. Multiple Imputation for Non-response in Surveys (Wiley, 1987).","DOI":"10.1002\/9780470316696"},{"key":"57990_CR33","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/ije\/28.5.964","volume":"28","author":"P Royston","year":"1999","unstructured":"Royston, P., Ambler, G. & Sauerbrei, W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int. J. Epidemiol. 28, 964\u2013974 (1999).","journal-title":"Int. J. Epidemiol."},{"key":"57990_CR34","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1002\/sim.8991","volume":"40","author":"DC Dover","year":"2021","unstructured":"Dover, D. C. et al. Computing the polytomous discrimination index. Stat. Med. 40, 3667\u20133681 (2021).","journal-title":"Stat. Med."},{"key":"57990_CR35","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/sim.5321","volume":"31","author":"B Van Calster","year":"2012","unstructured":"Van Calster, B. et al. Extending the c-statistic to nominal polytomous outcomes: the Polytomous Discrimination Index. Stat. Med. 31, 2610\u20132626 (2012).","journal-title":"Stat. Med."},{"key":"57990_CR36","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/sim.6114","volume":"33","author":"K Van Hoorde","year":"2014","unstructured":"Van Hoorde, K. et al. Assessing calibration of multinomial risk prediction models. Stat. Med. 33, 2585\u20132596 (2014).","journal-title":"Stat. Med."},{"key":"57990_CR37","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers, A. J., Van Calster, B. & Steyerberg, E. W. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352, i6 (2016).","journal-title":"BMJ"},{"key":"57990_CR38","doi-asserted-by":"crossref","unstructured":"Pate, A. et al. Minimum sample size for developing a multivariable prediction model using multinomial logistic regression. Stat. Methods Med. Res. 32 555\u2013571 (2023).","DOI":"10.1177\/09622802231151220"},{"key":"57990_CR39","doi-asserted-by":"crossref","unstructured":"Riley, R. D. et al. Minimum sample size calculations for external validation of a clinical prediction model with a binary outcome. Stat. Med. 40, 4230\u20134251 (2021).","DOI":"10.1002\/sim.9025"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57990-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57990-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57990-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:01:57Z","timestamp":1746608517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57990-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57990"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57990-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the ICMJE uniform disclosure form at  and declare: J.H.C. reports grants from National Institute for Health Research, John Fell Oxford University Press Research Fund, Cancer Research U.K. (C5255\/A18085), and other research councils, during the conduct of the study. J.H.C. is an unpaid director of QResearch, a not-for-profit organisation which is a partnership between the University of Oxford and EMIS Health who supply the QResearch database used for this work. Until 9 Aug 2023, J.H.C. had a 50% shareholding in ClinRisk Ltd, co-owning it with her husband, who was an executive director. On 9 August 2023, 100% of the share capital was donated to Endeavour Health Care Charitable Trust and the company was renamed to Endeavour Predict Ltd. J.H.C. is a consultant to Endeavour Predict Ltd. and her husband is a non-executive director to cover the transition. The company licences software both to the private sector and to NHS bodies or bodies that provide services to the NHS (through GP electronic health record providers, pharmacies, hospital providers and other NHS providers). This software implements algorithms (including QRISK3) developed from access to the QResearch database during her time at the University of Nottingham. C.C. reports receiving personal fees from ClinRisk Ltd., outside this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3660"}}